This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting central nervous system disorders. The trifluoromethyl group enhances the compound's bioavailability and metabolic stability, making it a crucial component in the design of potent and selective inhibitors. It is often employed in the research and production of compounds with potential antidepressant, anxiolytic, or antipsychotic properties. Additionally, its unique chemical properties contribute to its use in organic synthesis for creating complex molecules with specific biological activities.